STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 54 filers reported holding STOKE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $248,611 | -44.7% | 18,402 | -44.8% | 0.00% | -66.7% |
| Q1 2024 | $449,901 | +525.6% | 33,326 | +82.6% | 0.00% | +200.0% |
| Q3 2023 | $71,913 | -62.9% | 18,252 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $194,019 | +127544.1% | 18,252 | +0.3% | 0.00% | 0.0% |
| Q1 2023 | $152 | -10.1% | 18,199 | -0.6% | 0.00% | -33.3% |
| Q4 2022 | $169 | -99.9% | 18,313 | 0.0% | 0.00% | -40.0% |
| Q3 2022 | $235,000 | +8.3% | 18,313 | +11.5% | 0.01% | -16.7% |
| Q2 2022 | $217,000 | -41.2% | 16,424 | -6.3% | 0.01% | -33.3% |
| Q1 2022 | $369,000 | -21.0% | 17,519 | -10.1% | 0.01% | +12.5% |
| Q4 2021 | $467,000 | +113.2% | 19,477 | +159.7% | 0.01% | +33.3% |
| Q2 2019 | $219,000 | – | 7,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $475,340,000 | 79.82% |
| RTW INVESTMENTS, LP | 3,544,248 | $100,373,000 | 3.79% |
| Cormorant Asset Management, LP | 1,788,643 | $50,654,000 | 2.02% |
| RA Capital Management | 1,119,963 | $31,717,000 | 0.96% |
| Redmile Group, LLC | 1,020,778 | $28,908,000 | 0.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 256,380 | $7,261,000 | 0.60% |
| GILDER GAGNON HOWE & CO LLC | 1,826,890 | $51,738,000 | 0.54% |
| Perceptive Advisors | 671,978 | $19,030,000 | 0.38% |
| Casdin Capital, LLC | 130,000 | $3,682,000 | 0.34% |
| Granite Point Capital Management, L.P. | 13,200 | $374,000 | 0.06% |